An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.
Experimental Drug Gaining Traction Via Social Media
The experimental drug, which is still in research studies, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are encouraged to message these accounts privately for source information, while also obtaining discount codes.
Thriving Trade on Messaging Platforms
Additionally, a flourishing market exists on messaging services, where groups with thousands of participants share “before and after” images, administration instructions and claims of next-day British shipping. Sellers promote the substance there before redirecting buyers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.
Medical Experts Voice Concerns
However, physicians and pharmacists have cautions that the sale of what is still an unapproved medication in the United Kingdom is a cause for concern and could lead to users injecting products of uncertain source.
Several experts stated the demand for retatrutide could be connected to the increasing price of approved weight loss treatments such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be promoted or distributed for human use under the British medical regulations.
Several content creators attempt to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach medicines, marketing, and customer regulations, risking fines, prosecution or prison.
Platform Response and Material Removal
Based on TikTok, the service has removed violative material and prohibited related hashtags and search suggestions. The organization said it was dedicated to maintaining the platform secure and investing in strengthening enforcement strategies.
Online Trading Operations
Research also found communities with up to 9,000 members selling retatrutide using the platform's integrated search feature, which functions like a public directory. Typing “retatrutide” immediately displays groups with thousands of users, filled with images of weight loss, glowing testimonials and detailed instructions for mixing or administering at residence.
After minutes of joining one community, a seller shared contact information, where the majority of transactions occur. The seller sent an guidebook and promised shipping within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about body mass, health issues or previous experience.
Item Information and Pricing
Inside these groups, posts show black plastic packages with postal service labels, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at residence with purified liquid, or pre-filled pens usually sold at £160 for 20 milligrams. When asked how long a pen should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.
Platform Oversight and Safety Actions
A representative for Telegram stated it regularly monitored harmful content on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are administering substances they can’t verify. Even if the research behind this drug is sound, these online products may not contain what they claim,” stated Jason Murphy, the head of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor connected the increase in interest to current price rises for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are using social media. But fake injections are highly dangerous. You cannot know what’s contained or whether the conditions they were made in was sterile,” she said.
Her team has previously encountered patients injured by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” stated Wyllie. “These materials could be impure or improperly measured.”
Manufacturer Position
A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a company investigational product not yet approved … may subject patients to possibly serious medical dangers”.
